| |
GeNeuro – A revolutionary approach for the therapy of pathologies associated with human endogenous retroviruses expression.
GeNeuro is dedicated to the development of innovative therapeutics for severe pathologies triggered by human endogenous retroviruses by neutralizing the envelope protein that activates upstream the pro – inflammatory and autoimmune cascades.
|
|
GeNeuro is focusing primarily on Nervous System Disorders and is currently developing its first therapeutic humanized monoclonal antibodies for multiple sclerosis, a disease that today severely impairs people in our society.
GeNeuro is aiming to reach therapeutic advantage over existing drugs by acting specifically upstream the pro-inflammatory de-myelinating cascade, thus increasing efficacy and safety.
GeNeuro orients its therapeutic product pipeline development toward neurological and other diseases with high unmet medical needs.
| |
